A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
Clinical trial NCT07015983 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07015983
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-14
- Primary completion
- 2028-05-17
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.